Although several previous studies confirmed the connection between higher survivin levels and unfavorable outcomes of non-small cell lung cancer and other types of tumors, we did not find correlation between pre-treatment survivin concentrations and the survival parameters of patients. Here, BIRC5 is linked to non-small cell lung carcinoma.